Compare Medtronic PLC (MDT) vs Payoneer Global Inc (PAYO) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Medtronic PLC vs Payoneer Global Inc — how do they compare? Medtronic PLC trades at $83.21 (market cap $106.61B), while Payoneer Global Inc trades at $7.13 (market cap $2.41B). The key difference: Medtronic PLC is far larger — about 44.2× Payoneer Global Inc's market cap, and Medtronic PLC pays a 3.46% dividend while Payoneer Global Inc pays none. Which is the better fit depends on your goals.
| MDT | PAYO | |
|---|---|---|
Market Cap | $106.61B | $2.41B |
Sector | Health | Technology |
52-Week High | $105.35 | $7.42 |
52-Week Low | $73.75 | $4.27 |
Enterprise Value | $125.36B | $2.15B |
Dividend Yield | 3.46% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Medtronic (MDT) trades at $83.54, up 0.41% today, with a bullish technical signal from moving averages. The company reported strong revenue growth to $33.54B in 2025 and has beaten EPS estimates for three consecutive quarters. Recent acquisitions, including SPR and Scientia Vascular, expand its pain therapy and neurovascular portfolios. Valuation ratios show a P/E of 22.31 and P/S of 2.95, with a consensus price target of $97.50 implying significant upside.
The outlook is positive, supported by robust fundamentals, analyst optimism, and strategic expansions. Key risks include rising debt levels and competitive pressures in medical technology. With no sell ratings from analysts and a dividend yield near a decade high, MDT presents a compelling long-term opportunity for growth and income investors, though macroeconomic and execution risks warrant monitoring.
Payoneer (PAYO) trades at $7.125, up 0.07% today, with a strong technical outlook as moving averages signal bullish momentum. The company reported revenue of $821.16M in 2025, with a net income margin of 8.57%, though earnings have shown volatility with recent beats and misses. Recent news highlights a pending $2.75 billion acquisition by Nuvei, announced June 15, 2026, which has driven significant investor attention and legal scrutiny over the fairness of the $7.40 per share offer.
The acquisition by Nuvei presents a near-term catalyst, but shareholder lawsuits question the deal price. Analyst consensus is bullish with a $8.20 price target, yet execution risks and integration challenges post-acquisition could impact long-term value. Investors should weigh the premium offered against potential standalone growth prospects in the competitive fintech space.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Medtronic PLC
One of the largest medical device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for almost 50% of the company's total sales.
Read more on MDT →About Payoneer Global Inc
Payoneer Global Inc is the world's go-to partner for digital commerce, everywhere. The company started as a cross-border payments platform that empowers businesses, online sellers, and freelancers. The platform allows the users to get paid in multiple currencies, bill global clients, and sell on marketplaces worldwide.
Read more on PAYO →
